all report title image
  • Published On : Jan 2022
  • Code : CMI4865
  • Industry : Medical Devices
  • Pages : 123
  • Formats :

A pacemaker is inserted in the chest to help manage the heartbeat of patient. It is used from preventing the heart from beating slowly. It requires surgical procedure to insert a pacemaker in the chest. Pacemaker is also known as cardiac pacing device. The pacemaker starts sending the electrical signals if the heartbeat is slow to correct the beat. The new pacemakers have the sensors which detect the body motion or breathing rate and signals the device to increase the heart rate through the exercise, as per needed. Pacemaker has 2 parts: pulse generator and lead (electrodes). The pacemaker would stop functioning because of some electrical involvement, such as Cell phones, Security systems, medical equipment, and power-generating equipment.

Some pacemakers can also help the chambers of heartbeat in sync. Brazil cardiac pacemakers market would witness a significant growth during the forecast period (2021 - 2028), owing to increasing need of cardiac pacemaker implantation due to high prevalence of Chagas disease and growing trend of medical tourism in Brazil.

Brazil cardiac pacemakers market is estimated to be valued at US$ 305 million in 2021 and is expected to exhibit a CAGR of 2.4% over the forecast period (2021-2028).

Figure 1. Brazil Cardiac Pacemakers Market Value (US$ Mn), By Product Type, 2021

Brazil Cardiac Pacemakers  | Coherent Market Insights

Figure 1.1 Brazil Cardiac Pacemakers Market Value (US$ Mn), By Product Type, 2028

Brazil Cardiac Pacemakers  | Coherent Market Insights

CMI table icon

Hydroxychloroquine Market Report Coverage

Report Coverage Details
Base Year: 2020 Market Size in 2021: US$ 305 Mn
Historical Data for: 2017 to 2020 Forecast Period: 2021 to 2028
Forecast Period 2021 to 2028 CAGR: 2.4% 2028 Value Projection: US$ 359.3 Mn
Geographies covered:
  • Brazil
Segments covered:
  • By Product Type: Implantable Cardiac Pacemaker, External Cardiac Pacemaker
  • By Technology: Single Chamber Pacemaker, Dual Chamber Pacemaker, Biventricular Pacemaker
  • By End Users: Hospitals, Cardiac Clinics, Ambulatory Surgery Centers
Companies covered:

BIOTRONIK SE & Co.KG, Medtronic plc., Boston Scientific Corporation, Abbott Laboratories, LivaNova plc., Osypka Medical GmbH, and MEDICO S.p.A.

Growth Drivers:
  • Increasing Need for Adoption of Cardiac Pacemakers
  • Growing Trend of Medical Tourism in Brazil
Restraints & Challenges:
  • Infections Associated with Cardiac Pacemaker Implantation 
Opportunities:
  • Combined Efforts of Government and Key Market Players to Increase Patient Access

Figure 2. Brazil Cardiac Pacemakers Market Value (US$ Mn), By Technology, 2021

Brazil Cardiac Pacemakers  | Coherent Market Insights

Figure 2.1 Brazil Cardiac Pacemakers Market Value (US$ Mn), By Technology, 2028

Brazil Cardiac Pacemakers  | Coherent Market Insights

Various government and private organizations are focused on initiatives for increasing awareness regarding Chagas disease, which is expected to increase treatment rate, and adoption rate of cardiac pacemakers in Brazil.

The increasing product launches and approvals are expected to drive the market growth over the forecast period.

For instance, in August 2017, the U.S. FDA assured an alert regarding the security flaws in 465, 000 pacemakers of Abbott Laboratories and recalled them, stating that, these pacemaker may be vulnerable to hacking.

According to U.S. FDA, security flaws allows hackers to reprogram the devices to run the batteries down or modify the patients’ heartbeat, putting millions of patients’ lives at risk.

Brazil Cardiac Pacemakers Market – Impact of Coronavirus (Covid-19) Pandemic

Coronavirus (COVID-19) outbreak was first reported on December 31, 2019, in Wuhan, China. The World Health Organization declared COVID-19 as pandemic on March 11, 2020. According to the Coronavirus (COVID-19) Weekly Epidemiological Update by the World Health Organization, over 3.3 million new cases were reported, across the globe.

The COVID-19 pandemic and lockdown in various countries across the globe has negatively impacted the financial status of businesses across all sectors. The COVID-19 pandemic has impacted the entire supply chain of the healthcare industry mainly due to strict lockdown in several regions. Likewise, COVID-19 pandemic is expected to have a negative impact on Cardiac Pacemakers Market Cardiac Pacemakers Market            

For instance, as per National Library of Medicine, reduction in pacemaker implantation of 73% was noticed within the COVID-19 pandemic period, and reduction of 78% in patients with the treatment of complete atrioventricular block and reduction in de-novo pacemaker insert was noticed.

Brazil Cardiac Pacemakers Market Restraint

Cardiac pacemaker infections are complex to manage, as there are intra-cardiac and extra-cardiac components, which may get infected and removal of the device is associated with a risk of death or significant complications. Long term hospital stays and multiple in-patient hospital admissions are common in pacemaker infections and efforts to treat infected systems often results in unnecessarily prolonged courses of treatment. Furthermore, cardiac pacemaker infections can be difficult to diagnose. The diagnosis is more difficult in infective endocarditis (IE) as echocardiography is less accurate, blood cultures are less sensitive, and the diagnosis is often not considered.

Key Players

Major players operating in the Brazil cardiac pacemakers market include BIOTRONIK SE & Co.KG, Medtronic plc., Boston Scientific Corporation, Abbott Laboratories, Ivanovo plc., Osyka Medical GmbH, MEDICO S.p.A

Cardiac pacemaker are medical device that supply impulses to the conduction system to originate contraction. The first cardiac pacemaker was introduced (Alee and Bernstein, 2001) in 1958, since then cardiac pacing has become a well-established therapeutic tool. Most cardiac pacemakers are inserted in patients above 60 years old and are also utilized in children, involving infants, if necessary. There are various types of conduction block which is most common indication for permanent cardiac pacing. Some leads to Bradycardia, which can result in ventricular dyssynchrony and ineffective ventricular contraction in normal heart rate.

The indications are sent to heart by electrical impulses which helps in producing a heartbeat. There are also some pacemakers which work as per needed. The patient is not allowed to drive a car for a week after insertion of the pacemaker.

Market Dynamics

The increasing need for adoption of cardiac pacemakers, growing trend of medical tourism in Brazil, and increasing adoption of inorganic growth strategies such as mergers, acquisitions, partnerships, and collaborations by key players operating in the market are the major factors that are expected to drive growth of the Brazil cardiac pacemakers market over the forecast period.

Cardiac pacemakers are increasingly used in the Chagas disease, which is highly endemic in 21 countries of Latin America, primarily transmitted by large, blood-sucking reduviid insects widely known as 'the kissing bugs' and by other means such as blood transfusion, organ transplantation, as well as congenital and oral transmissions. For instance, as per stated in National Library of Medicine 25%-30% of cardiac stimulation were performed in 2017 for Chagas disease in Brazil according to Brazil Pacemaker Registry (BPR)

Key features of the study:

  • This report provides in-depth analysis of the Brazil cardiac pacemakers market, and provides market size (US$ Mn) and compound annual growth rate (CAGR%) for the forecast period (2021–2028), considering 2020 as the base year
  • It elucidates potential revenue opportunities across different segments and explains attractive investment proposition matrices for this market
  • This study also provides key insights about market drivers, restraints, opportunities, new product launches or approval, market trends,  regional outlook, and competitive strategies adopted by key players
  • It profiles key players in the Brazil cardiac pacemakers market based on the following parameters – company overview, financial performance, product portfolio, market presence, distribution strategies, key developments, strategies, and future plans
  • Key companies covered as a part of this study include BIOTRONIK SE & Co.KG, Medtronic plc., Boston Scientific Corporation, Abbott Laboratories, LivaNova plc., Osypka Medical GmbH, MEDICO S.p.A.
  • Insights from this report would allow marketers and the management authorities of the companies to make informed decisions regarding their future product launches, type up-gradation, market expansion, and marketing tactics
  • The Brazil cardiac pacemakers market report caters to various stakeholders in this industry including investors, suppliers, product manufacturers, distributors, new entrants, and financial analysts
  • Stakeholders would have ease in decision-making through various strategy matrices used in analyzing the Brazil cardiac pacemakers market.

Detailed Segmentation:

  • Brazil Cardiac Pacemakers Market, By Product Type:
    • Implantable cardiac pacemaker
    • External cardiac pacemaker
  • Brazil Cardiac Pacemakers Market, By Technology:
    • Single chamber pacemaker
    • Dual chamber pacemaker
    • Biventricular pacemaker
  • Brazil Cardiac Pacemakers Market, By End Users:
    • Hospitals
    • Cardiac clinics
    • Ambulatory surgery centers
  • Company Profiles
    • BIOTRONIK SE & Co.KG
      • Company highlights
      • Product Portfolio
      • Key Highlights
      • Financial performance
      • Strategies
    • Medtronic plc.
      • Company highlights
      • Product Portfolio
      • Key Highlights
      • Financial performance
      • Strategies
    • Boston Scientific Corporation
      • Company highlights
      • Product Portfolio
      • Key Highlights
      • Financial performance
      • Strategies
    • Abbott Laboratories
      • Company highlights
      • Product Portfolio
      • Key Highlights
      • Financial performance
      • Strategies
    • LivaNova plc.
      • Company highlights
      • Product Portfolio
      • Key Highlights
      • Financial performance
      • Strategies
    • Osypka Medical GmbH
      • Company highlights
      • Product Portfolio
      • Key Highlights
      • Financial performance
      • Strategies
    • MEDICO S.p.A.
      • Company highlights
      • Product Portfolio
      • Key Highlights
      • Financial performance
      • Strategies

“*” marked represents similar segmentation in other categories in the respective section.

Frequently Asked Questions

Brazil cardiac pacemakers market size is estimated to be valued at US$ 359.3 million in 2028 and is expected to exhibit a CAGR of 2.4% between 2021 and 2028.
The increasing need for adoption of cardiac pacemakers, growing trend of medical tourism, and combined efforts of government and key market players to increase patient access to service or facilities are the major factors which are expected to drive the market growth over the forecast period. 
Implantable Cardiac Pacemaker segment is expected to hold major market share over the forecast period, which are surgically implanted in the patient’s chest.
Major factors hampering growth of the market include infections Associated with cardiac pacemaker implantation as a treatment for bradyarrhythmias and other cardiac rhythm disorders.
Major players operating in the market include BIOTRONIK SE & Co.KG, Medtronic plc., Boston Scientific Corporation, Abbott Laboratories, LivaNova plc., Osypka Medical GmbH, and MEDICO S.p.A.

Related Reports

EXISTING CLIENTELE

Joining thousands of companies around the world committed to making the Excellent Business Solutions.

View All Our Clients
trusted clients logo